Skip Nav Destination

Mavorixafor Inhibits Pathogenic Cxcr4 Signaling and Function in T Lymphocytes from Patients with WHIM Syndrome in vitro

J Hum Immun (2025) 1 (CIS2025): CIS2025abstract.32.
Currently there are no citedby results. Try again later.